Status:
RECRUITING
Fecal Immunochemical Test for Post-polypectomy Surveillance to Reduce Unnecessary eNdoscopy
Lead Sponsor:
University of Calgary
Conditions:
Colorectal Neoplasms
Eligibility:
All Genders
18-74 years
Brief Summary
This is an observational study in a clinical setting to estimate the prevalence of advanced colorectal neoplasia (ACN) at colonoscopy in those with a history of low or high risk polyps or a family his...
Detailed Description
Colonoscopy is an effective tool in reducing colorectal cancer (CRC) incidence, however, it is a limited resource that is not without risk. The overall goal of this study is to determine if Fecal Immu...
Eligibility Criteria
Inclusion
- Men or women age ≤ 74 years of age.
- At least one risk factor for CRC that would generally lead to colonoscopy screening:
- Personal history of low risk polyps
- Personal history of high risk polyps
- Family history of CRC or polyps
Exclusion
- Known acromegaly, cystic fibrosis or high risk profession (firefighter)
- Referred for colonoscopy due to a positive fecal immunochemical test or CT colonography
- Known or suspected gene carrier for a familial cancer syndrome.
- Does not meet medical criteria for colonoscopy at the CCSC.
- Colonoscopy within the previous 30 months
- Unable to provide written informed consent or complete questionnaires due to language barrier or other reasons.
Key Trial Info
Start Date :
April 15 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 15 2027
Estimated Enrollment :
3000 Patients enrolled
Trial Details
Trial ID
NCT05396560
Start Date
April 15 2022
End Date
April 15 2027
Last Update
May 31 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Forzani & Macphail Colon Cancer Screening Centre, University of Calgary
Calgary, Alberta, Canada, T2N 4N1